NCT03382509View on ClinicalTrials.gov

This Study Tests BI 1467335 in Healthy Male Volunteers. The Study Tests How Different Doses of BI 1467335 Are Taken up and Handled by the Body

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

January 12, 2018

Primary Completion Date

April 19, 2018

Study Completion Date

April 19, 2018

Conditions
Healthy
Interventions
DRUG

[14C]BI 1467335

Once Daily

DRUG

BI 1467335

Twice Daily

Trial Locations (1)

9728 NZ

PRA Health Sciences Onderzoekscentrum Martini, Groningen

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY